Tokyo, Jan. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060212) titled 'Pemafibrate-Low-Density Lipoprotein Cholesterol Intervention Study' on Jan. 12.
Study Type:
Observational
Primary Sponsor:
Institute - Kindai University
Condition:
Condition - hyperlipidemia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to evaluate the effect of pemafibrate on LDL-C levels in patients with dyslipidemia who are receiving statin therapy, in a real-world clinical practice.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
100 mg/dL at the time of pemafibrate initiation
Individuals with triglyc...